已收盤 09-20 16:00:00 美东时间
+5.480
+10.35%
We'd be surprised if Apogee Therapeutics, Inc. (NASDAQ:APGE) shareholders haven...
08-25 21:30
Apogee Therapeutics Inc - Expects Apg990 Interim Data in 2025
08-19 19:01
Apogee Therapeutics Inc - to Initiate Apg777 and Apg990 Trial in 2025
08-19 19:01
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Tria...
08-19 19:00
Apogee Therapeutics (NASDAQ:APGE) files automatic shelf registration for potential mixed shelf offering. SEC Filing More on Apogee Therapeutics Apogee Therapeutics: Infrequent Dosing Advantage In Biot...
08-13 05:39
Apogee Therapeutics - Sales Agreement Prospectus Covering Offering of up to $30...
08-13 05:30
Apogee Therapeutics Inc Files for Mixed Shelf - SEC Filing
08-13 05:29
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Apogee Therapeutics...
08-13 00:45
Apogee Therapeutics press release (NASDAQ:APGE): Q2 net loss of $33.8 million, compared to the net loss for the second quarter of 2023 which was $18.9 million. Net loss increased primarily as a result...
08-12 18:46
Apogee Therapeutics: Phase 1 Apg990 Hv Clinical Trial Set to Start Ahead of Sch...
08-12 18:31